2012Unpublished venueRequires access

Combination of tamsulosin and solifenacin treatment for benign prostatic hyperplasia with overactive bladder

Qian Yang

Open publisher page 1 citations

Abstract

Objective To evaluate the efficacy of tamsulosin combined with solifenacin on BPH with overactive bladder.Methods 85 BPH patients with overactive bladder were randomly divided into single group(n=45)and combination group(n=40).The single group was treated with 0.2 mg tamsulosin once daily for 12 weeks,and the combination group was treated with 0.2 mg tamsulosin and 5 mg solifenacin once daily for 12 weeks.Before and after the treatment,we recorded the International Prostate Symptoms Score(IPSS),quality of life score(QOL),Overactive Bladder Symptoms Score(OABSS),Qmax,and the adverse events.Results In the single group,the IPSS,QOL,Qmax was improved(P0.05).In the combination group,the improvement of IPSS,QOL and OABSS were more significant than those of single group(P0.05).Conclusion The combined use of tamsulosin and solifenacin could not only relieve obstructive symptoms,but also relieve overactive bladder symptoms of BPH patients.

About this research paper

What this paper is about

Objective To evaluate the efficacy of tamsulosin combined with solifenacin on BPH with overactive bladder.Methods 85 BPH patients with overactive bladder were randomly divided into single group(n=45)and combination group(n=40).The single group was treated with 0.2 mg tamsulosin once daily for 12 weeks,and the combination group was treated with 0.2 mg tamsulosin and 5 mg solifenacin once daily for 12 weeks.Before and after the treatment,we recorded the International Prostate Symptoms Score(IPSS),quality of life score(QOL),Overactive Bladder Symptoms Score(OABSS),Qmax,and the adverse events.Results In the single group,the IPSS,QOL,Qmax was improved(P0.05).In the combination group,the improvement of IPSS,QOL and OABSS were more significant than those of single group(P0.05).Conclusion The combined use of tamsulosin and solifenacin could not only relieve obstructive symptoms,but also relieve overactive bladder symptoms of BPH patients.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the efficacy of tamsulosin combined with solifenacin on BPH with overactive bladder.Methods 85 BPH patients with overactive bladder were randomly divided into single group(n=45)and combination group(n=40).The single group was treated with 0.2 mg tamsulosin once daily for 12 weeks,and the combination group was treated with 0.2 mg tamsulosin and 5 mg solifenacin once daily for 12 weeks.Before and after the treatment,we recorded the International Prostate Symptoms Score(IPSS),quality of life score(QOL),Overactive Bladder Symptoms Score(OABSS),Qmax,and the adverse events.Results In the single group,the IPSS,QOL,Qmax was improved(P0.05).In the combination group,the improvement of IPSS,QOL and OABSS were more significant than those of single group(P0.05).Conclusion The combined use of tamsulosin and solifenacin could not only relieve obstructive symptoms,but also relieve overactive bladder symptoms of BPH patients.

Key concepts: Solifenacin, Tamsulosin, Overactive bladder, Medicine, Urology, International Prostate Symptom Score, Quality of life (healthcare), Hyperplasia

Related papers

Back to paper searchBrowse research topicsOriginal source
Combination of tamsulosin and solifenacin treatment for benign prostatic hyperplasia with overactive bladder — Research Paper | ScholarLens